Yestar Healthcare Holdings Company Limited (2393.HK)

HKD 0.06

(-4.69%)

EBITDA Summary of Yestar Healthcare Holdings Company Limited

  • Yestar Healthcare Holdings Company Limited's latest annual EBITDA in 2023 was 376.8 Million CNY , up 610.69% from previous year.
  • Yestar Healthcare Holdings Company Limited's latest quarterly EBITDA in 2024 Q2 was 75.35 Million CNY , down 0.0% from previous quarter.
  • Yestar Healthcare Holdings Company Limited reported an annual EBITDA of 19.13 Million CNY in 2022, down -86.06% from previous year.
  • Yestar Healthcare Holdings Company Limited reported an annual EBITDA of 315.88 Million CNY in 2021, up 3.4% from previous year.
  • Yestar Healthcare Holdings Company Limited reported a quarterly EBITDA of 160.44 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Yestar Healthcare Holdings Company Limited reported a quarterly EBITDA of N/A for 2023 FY, up 610.69% from previous quarter.

Annual EBITDA Chart of Yestar Healthcare Holdings Company Limited (2023 - 2012)

Historical Annual EBITDA of Yestar Healthcare Holdings Company Limited (2023 - 2012)

Year EBITDA EBITDA Growth
2023 376.8 Million CNY 610.69%
2022 19.13 Million CNY -86.06%
2021 315.88 Million CNY 3.4%
2020 -317.26 Million CNY -60.14%
2019 766.38 Million CNY -4.49%
2018 802.42 Million CNY 2.4%
2017 783.62 Million CNY 52.23%
2016 514.75 Million CNY 47.24%
2015 349.59 Million CNY 112.38%
2014 164.6 Million CNY 54.36%
2013 106.64 Million CNY 13.06%
2012 94.32 Million CNY 0.0%

Peer EBITDA Comparison of Yestar Healthcare Holdings Company Limited

Name EBITDA EBITDA Difference
Vincent Medical Holdings Limited 104.43 Million HKD -260.814%